Zensights Names Roderick Cavin as Principal

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Zensights LLC is pleased to announce that Roderick Cavin has joined the organization as a Principal. Rod is a proven leader in the bio-pharmaceutical and medical device markets with extensive expertise and knowledge of U.S. and EU market access. He has engaged with clients ranging from large pharma to early-stage device firms in product launch, organizational design, market access/pricing, vendor selection, and large customer engagement. In addition, he brings the unique experience of having successfully built and sold a leading research and syndicated data firm.

Rod is a welcome addition to the Zensights team and brings the experience of building sustainable client growth by identifying key business challenges and linking strategy to tactical plans with clear measures. In this new role, Rod will lead client engagements and support the growth of the multi-client product platforms.

Bob Jansen, CEO of Zensights stated, “Rod has tremendous experience in the payer space and has supported pharma and biotech companies in all phases of their growth trajectory. His insights and understanding of the U.S. and EU payer landscapes will prove to be incredibly valuable for our clients.”

About Zensights

Founded in 2012, Zensights is focused on helping BioPharma organizations improve business results by building relationships with “Best in Class” vendors on a “capability by capability” perspective. For pharmaceutical and biotech business leaders looking to optimize services using a new or existing vendor partner, Zensights provides software, advanced consulting, vetting, and executive connections to help commercial and procurement partners secure high-quality, fit-for-purpose, cost-effective contracts and solutions to drive business results.